The Role of Mitochondrial Genes in Neurodegenerative Disorders
暂无分享,去创建一个
A. Alexiou | G. Batiha | Seetha Harilal | D. G. Thomas Parambi | Md. Atiar Rahman | Rajesh Kumar | S.K. Kanthlal | Bijo Mathew
[1] Hoon Kim,et al. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors. , 2020, ACS combinatorial science.
[2] D. G. Parambi,et al. Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson’s Disease , 2020, Neurochemical Research.
[3] T. Behl,et al. Molecular mechanism of zinc neurotoxicity in Alzheimer’s disease , 2020, Environmental Science and Pollution Research.
[4] N. Bresolin,et al. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease , 2020, Molecular Neurobiology.
[5] D. G. Parambi,et al. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules , 2020, Brain Research Bulletin.
[6] D. G. Parambi,et al. Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives , 2019, The Journal of pharmacy and pharmacology.
[7] Nidhi Sharma,et al. Mitochondrial DNA: Epigenetics and environment , 2019, Environmental and molecular mutagenesis.
[8] Jong Seung Kim,et al. Direct readout protonophore induced selective uncoupling and dysfunction of individual mitochondria within cancer cells. , 2019, Chemical communications.
[9] F. Coppedè,et al. Mitoepigenetics and Neurodegenerative Diseases , 2019, Front. Endocrinol..
[10] A. Alexiou,et al. Role of GTPases in the Regulation of Mitochondrial Dynamics in Alzheimer’s Disease and CNS-Related Disorders , 2018, Molecular Neurobiology.
[11] S. Shaji,et al. (I-3,II-3)-Biacacetin-mediated cell death involves mitochondria , 2018, Molecular and Cellular Biochemistry.
[12] K. Wimalasena,et al. Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP+ , 2018, bioRxiv.
[13] Faez Iqbal Khan,et al. Mitochondrial Dynamics and Proteins Related to Neurodegenerative Diseases. , 2017, Current protein & peptide science.
[14] J. Strosznajder,et al. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders , 2016, Neurochemical Research.
[15] Liu Yang,et al. Aging-related 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurochemial and behavioral deficits and redox dysfunction: improvement by AK-7 , 2016, Experimental Gerontology.
[16] M. Barrachina,et al. Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease. , 2016, The American journal of pathology.
[17] M. Keogh,et al. Mitochondrial DNA mutations in neurodegeneration. , 2015, Biochimica et biophysica acta.
[18] J. Strosznajder,et al. The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins , 2015, PloS one.
[19] Man Zhang,et al. Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer’s Disease , 2015, Neurochemical Research.
[20] M. Duchen,et al. PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s , 2014, Neurochemical Research.
[21] Laura C. Greaves,et al. Similar patterns of clonally expanded somatic mtDNA mutations in the colon of heterozygous mtDNA mutator mice and ageing humans , 2014, Mechanisms of Ageing and Development.
[22] João Carneiro,et al. Mitochondrial DNA Rearrangements in Health and Disease—A Comprehensive Study , 2014, Human mutation.
[23] M. Lovell,et al. Epigenetic changes in the progression of Alzheimer's disease , 2013, Mechanisms of Ageing and Development.
[24] M. Elstner,et al. Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease , 2013, Neurobiology of Aging.
[25] T. Prolla,et al. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. , 2013, Brain : a journal of neurology.
[26] M. Chesselet,et al. Mitochondrial dysfunction and oxidative stress in Parkinson's disease , 2013, Progress in Neurobiology.
[27] David C. Samuels,et al. Universal heteroplasmy of human mitochondrial DNA , 2012, Human molecular genetics.
[28] Perry G. Ridge,et al. Mitochondrial Genomic Analysis of Late Onset Alzheimer’s Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging , 2012, PloS one.
[29] D. Bogenhagen. Mitochondrial DNA nucleoid structure. , 2012, Biochimica et biophysica acta.
[30] V. Petruzzella,et al. Mitochondrial genome large rearrangements in the skeletal muscle of a patient with PMA , 2012, European journal of neurology.
[31] Nick C Fox,et al. No consistent evidence for association between mtDNA variants and Alzheimer disease , 2012, Neurology.
[32] I. McKeith,et al. Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons. , 2012, Archives of neurology.
[33] L. Martin,et al. Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation , 2011, The Journal of Neuroscience.
[34] K. Khrapko. The timing of mitochondrial DNA mutations in aging , 2011, Nature Genetics.
[35] Trygve E Bakken,et al. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort , 2010, Neurobiology of Aging.
[36] P. Rothwell,et al. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study , 2010, The Lancet Neurology.
[37] Robert W. Taylor,et al. Mitochondrial DNA mutations and human disease. , 2010, Biochimica et biophysica acta.
[38] N. Lax,et al. The mitochondrial brain: From mitochondrial genome to neurodegeneration , 2010, Biochimica et biophysica acta.
[39] M. Rossi,et al. Mitochondrial Localization of PARP-1 Requires Interaction with Mitofilin and Is Involved in the Maintenance of Mitochondrial DNA Integrity* , 2009, The Journal of Biological Chemistry.
[40] D. Turnbull,et al. Do organellar genomes function as long-term redox damage sensors? , 2009, Trends in genetics : TIG.
[41] P. Pinton,et al. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. , 2009, Biochimica et biophysica acta.
[42] Manfred Kayser,et al. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation , 2009, Human mutation.
[43] Jie-Jin Wang,et al. Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community , 2009, Movement disorders : official journal of the Movement Disorder Society.
[44] S. Mitra,et al. Long Patch Base Excision Repair in Mammalian Mitochondrial Genomes* , 2008, Journal of Biological Chemistry.
[45] R. Maletta,et al. No evidence of association between frontotemporal dementia and major European mtDNA haplogroups , 2008, European journal of neurology.
[46] Keith W. Caldecott,et al. Single-strand break repair and genetic disease , 2008, Nature Reviews Genetics.
[47] C. Meissner,et al. The 4977bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: A useful biomarker or more? , 2008, Experimental Gerontology.
[48] R. Scarpulla. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. , 2008, Physiological reviews.
[49] David C Samuels,et al. What causes mitochondrial DNA deletions in human cells? , 2008, Nature Genetics.
[50] A. Plaitakis,et al. Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background , 2008, Journal of Human Genetics.
[51] Robert W. Taylor,et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. , 2008, Brain : a journal of neurology.
[52] J. Elson,et al. Strong Purifying Selection in Transmission of Mammalian Mitochondrial DNA , 2008, PLoS biology.
[53] Z. Chrzanowska-Lightowlers,et al. How do mammalian mitochondria synthesize proteins? , 2007, Biochemical Society transactions.
[54] W. Tate,et al. mtRF1a Is a Human Mitochondrial Translation Release Factor Decoding the Major Termination Codons UAA and UAG , 2007, Molecular cell.
[55] A. Bacci,et al. Lack of association between mtDNA haplogroups and Alzheimer’s disease in Tuscany , 2007, Neurological Sciences.
[56] J. Jankovic,et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease , 2007, Neurology.
[57] Pierre Baldi,et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny , 2006, Nucleic Acids Res..
[58] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[59] Robert W. Taylor,et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.
[60] Laura C. Greaves,et al. Mitochondrial DNA mutations in human disease , 2006, IUBMB life.
[61] D. Turnbull,et al. mtDNA mutations and common neurodegenerative disorders. , 2005, Trends in genetics : TIG.
[62] M. Beal,et al. Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.
[63] M. van der Giezen,et al. Degenerate mitochondria , 2005, EMBO reports.
[64] M. T. Pellecchia,et al. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians , 2005, European Journal of Human Genetics.
[65] Shamkant B. Navathe,et al. MITOMAP: a human mitochondrial genome database—2004 update , 2004, Nucleic Acids Res..
[66] M. Beal,et al. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[67] Howard T. Jacobs,et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase , 2004, Nature.
[68] I. Santana,et al. Frontotemporal dementia and mitochondrial DNA transitions , 2004, Neurobiology of Disease.
[69] A. Godzik,et al. Mitochondrial fission in apoptosis, neurodegeneration and aging. , 2003, Current opinion in cell biology.
[70] W. Kuhn,et al. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease , 2003, Neuroscience Letters.
[71] Jean-Pierre Mazat,et al. Mitochondrial threshold effects. , 2003, The Biochemical journal.
[72] M. Fardeau,et al. Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function , 2002, Neuromuscular Disorders.
[73] M. Beal,et al. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. , 2002, Human molecular genetics.
[74] M. Beal,et al. In Vivo Regulation of Oxidative Phosphorylation in Cells Harboring a Stop-codon Mutation in Mitochondrial DNA-encoded Cytochrome c Oxidase Subunit I* , 2001, The Journal of Biological Chemistry.
[75] P. Ince,et al. Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD , 2001, Neurology.
[76] D. Turnbull,et al. Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. , 2001, American journal of human genetics.
[77] T. Parsons,et al. Point mutations of the mtDNA control region in normal and neurodegenerative human brains. , 2001, American Journal of Human Genetics.
[78] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[79] P. Donnelly,et al. The mutation rate in the human mtDNA control region. , 2000, American journal of human genetics.
[80] H. Jacobs,et al. Coupled Leading- and Lagging-Strand Synthesis of Mammalian Mitochondrial DNA , 2000, Cell.
[81] G. Attardi,et al. Tight Control of Respiration by NADH Dehydrogenase ND5 Subunit Gene Expression in Mouse Mitochondria , 2000, Molecular and Cellular Biology.
[82] D. Turnbull,et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.
[83] B. Sykes,et al. Phylogeography of mitochondrial DNA in western Europe , 1998, Annals of human genetics.
[84] Massimo Zeviani,et al. Cytochrome c Oxidase subunit I microdeletion in a patient with motor neuron disease , 1998, Annals of neurology.
[85] F. Castora,et al. Elevated levels of the Kearns-Sayre syndrome mitochondrial DNA deletion in temporal cortex of Alzheimer's patients. , 1997, Mutation research.
[86] S. Weis,et al. Cytochrome c oxidase defects of the human substantia nigra in normal aging , 1996, Neurobiology of Aging.
[87] M. Murphy,et al. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. , 1996, The Biochemical journal.
[88] John X. Morris,et al. Increased risk of dementia in mothers of Alzheimer's disease cases , 1996, Neurology.
[89] J. Enríquez,et al. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNALys and premature translation termination , 1995, Nature Genetics.
[90] B. V. van Oost,et al. The relationship between mitochondrial genotype and mitochondrial phenotype in lymphoblasts with a heteroplasmic mtDNA deletion. , 1994, Human molecular genetics.
[91] H. Reichmann,et al. Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.
[92] C. Filley,et al. Electron transport chain defects in Alzheimer's disease brain , 1994, Neurology.
[93] J V Neel,et al. Asian affinities and continental radiation of the four founding Native American mtDNAs. , 1993, American journal of human genetics.
[94] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[95] E. Shoubridge,et al. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). , 1992, American journal of human genetics.
[96] M. Beal,et al. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age , 1992, Nature Genetics.
[97] N. Arnheim,et al. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain , 1992, Nature Genetics.
[98] J. Cooper,et al. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: Effect of ageing , 1992, Journal of the Neurological Sciences.
[99] D. Wallace,et al. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. , 1992, Mutation research.
[100] D. Shibata,et al. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[101] J. Nobrega,et al. Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.
[102] R. Wiesner,et al. Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. , 1992, Biochemical and biophysical research communications.
[103] R. Sternglanz,et al. Identification and characterization of yeast mutants and the gene for a cruciform cutting endonuclease. , 1992, The EMBO journal.
[104] J. Hayashi,et al. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[105] L. Spremulli,et al. Initiation of protein synthesis in animal mitochondria. Purification and characterization of translational initiation factor 2. , 1991, The Journal of biological chemistry.
[106] J. Müller‐Höcker. Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: An age-related alteration , 1990, Journal of the Neurological Sciences.
[107] C. Filley,et al. Cytochrome oxidase deficiency in Alzheimer's disease , 1990, Neurology.
[108] L. Spremulli,et al. Bovine mitochondrial protein synthesis elongation factors. Identification and initial characterization of an elongation factor Tu-elongation factor Ts complex. , 1989, The Journal of biological chemistry.
[109] J. Müller‐Höcker,et al. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart--an age-related phenomenon. A histochemical ultracytochemical study. , 1989, The American journal of pathology.
[110] Edward Byrne,et al. DECLINE IN SKELETAL MUSCLE MITOCHONDRIAL RESPIRATORY CHAIN FUNCTION: POSSIBLE FACTOR IN AGEING , 1989, The Lancet.
[111] B. Reisberg,et al. Positron emission tomographic studies of aging and Alzheimer disease. , 1983, AJNR. American journal of neuroradiology.
[112] D. A. Clayton,et al. Replication of animal mitochondrial DNA , 1982, Cell.
[113] F. Sanger,et al. Sequence and organization of the human mitochondrial genome , 1981, Nature.
[114] A. Alexiou,et al. Prediction of Alzheimer's disease , 2020 .
[115] A. Alexiou,et al. Recent developments in the etiology, treatment, and potential therapeutic targets for Parkinson's disease: a focus on biochemistry , 2020 .
[116] E. Hwang. Pharmacological Nicotinamide: Mechanisms Centered Around SIRT1 Activity , 2019, Pharmacoepigenetics.
[117] F. Coppedè,et al. Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[118] L. Polito,et al. Sirtuin Modulation as Novel Neuroprotective Strategy for Alzheimer’s Disease , 2017 .
[119] A. Reeve,et al. An Introduction to Mitochondria, Their Structure and Functions , 2016 .
[120] Yidong Bai,et al. Physiology and pathophysiology of mitochondrial DNA. , 2012, Advances in experimental medicine and biology.
[121] I. McKeith,et al. The relationship between mitochondria and α-synuclein-A study of single substantia nigra neurons , 2011 .